0.2571
1.01%
0.0002
Endra Life Sciences Inc stock is traded at $0.2571, with a volume of 773.68K.
It is up +1.01% in the last 24 hours and up +25.97% over the past month.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
See More
Previous Close:
$0.2569
Open:
$0.26
24h Volume:
773.68K
Relative Volume:
0.08
Market Cap:
$4.66M
Revenue:
-
Net Income/Loss:
$-10.06M
P/E Ratio:
-0.0774
EPS:
-3.32
Net Cash Flow:
$-9.58M
1W Performance:
-20.59%
1M Performance:
+25.97%
6M Performance:
-98.41%
1Y Performance:
-99.46%
Endra Life Sciences Inc Stock (NDRA) Company Profile
Name
Endra Life Sciences Inc
Sector
Industry
Phone
734-335-0468
Address
3600 GREEN COURT, ANN ARBOR, MI
Endra Life Sciences Inc Stock (NDRA) Latest News
ENDRA Life Sciences announces reverse stock split - Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14% - MSN
AWH Stock Plummets 6.19% Amid Weak Financial Performance - GuruFocus.com
3 Penny Stocks to Watch Now, 10/24/24 - TipRanks
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Why ENDRA Life Sciences (NDRA) Stock Is Up 140% - Benzinga
ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany - The Bakersfield Californian
ENDRA Life Sciences Inc. Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany - Marketscreener.com
Market Momentum Report: ENDRA Life Sciences Inc (NDRA)’s Negative Close at 0.21 - The Dwinnex
Examining ENDRA Life Sciences Inc (NDRA) stock is warranted - US Post News
ENDRA Life Sciences Inc (NDRA) Stock: A Year of Stock Market Dynamics - The InvestChronicle
The growth track for ENDRA Life Sciences Inc (NDRA) has changed recently - SETE News
ENDRA Life Sciences Inc’s latest rating changes from various analysts - Knox Daily
Should investors be concerned about NDRA’s high price-to-sales ratio? - US Post News
Stock Market Recap: ENDRA Life Sciences Inc (NDRA) Concludes at 0.19, a -4.83 Surge/Decline - The Dwinnex
Digital Realty Trust Inc [DLR] stock was sold by MANDEVILLE JEAN F H P at the price of US$90156.0 - Knox Daily
NEOG Stock Declines Amidst Market Volatility in Life Sciences Se - GuruFocus.com
Adversity is less terrifying than hope: ENDRA Life Sciences Inc (NDRA) - SETE News
ENDRA Life Sciences Inc (NDRA)’s Day in Review: Closing at 0.20, Down by -3.13 - The Dwinnex
ENDRA Life Sciences Inc (NDRA) is a good investment, but the stock may be overvalued - US Post News
A company insider recently sold 139,357 shares of Nuzee Inc [NUZE]. Should You Sale? - Knox Daily
The time has not yet come to remove your chips from the table: ENDRA Life Sciences Inc (NDRA) - SETE News
Benjamin F. Edwards & Company Inc. Purchases 693 Shares of Ingredion Incorporated (NYSE:INGR) - Defense World
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.36% - MSN
Ababaka ku kakiiko k’ebyobulamu barambudde fakitole ekola eddagala - NTV Uganda
ENDRA Life Sciences Inc: Analyzing NDRA Stock Trends - The InvestChronicle
INDIGO Biosciences Launches New Cell-Based Luciferase Reporter Assay for the Human Melanocortin 2 Receptor - EIN News
A closer look at ENDRA Life Sciences Inc (NDRA) is warranted - US Post News
Investor’s Delight: ENDRA Life Sciences Inc (NDRA) Closes Weak at 0.20, Down -6.77 - The Dwinnex
Insider Buys Additional ₹33m In NRB Bearings Stock - Simply Wall St
Balakrishna on VenkyAnil3 sets: Iddharu Sankranthike Vasthunnaru - TeluguOne News
Renaissance Technologies LLC Has $37.73 Million Stock Holdings in InMode Ltd. (NASDAQ:INMD) - Defense World
10:1 Stock Split Record Date Today: Multibagger Penny Stock Under Rs 10 Hit Upper Circuit & 52-Week High On September 19 - Dalal Street Investment Journal
ENDRA Life Sciences Inc (NDRA) can make a big difference with a little luck - SETE News
Ratio Examination: ENDRA Life Sciences Inc (NDRA)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Photoacoustic Imaging System Market Projected to Reach $327.13 Million by 2030 As Revealed In New Report - WhaTech
How did ENDRA Life Sciences Inc (NDRA) fare last session? - US Post News
NDRA’s Financial Health: Exploring ENDRA Life Sciences Inc’s Debt-to-Equity Ratio of 1.79 - The InvestChronicle
Closing Figures Unveiled: ENDRA Life Sciences Inc (NDRA) Drop -2.40, Closes at 0.24 - The Dwinnex
Check out these key findings about ENDRA Life Sciences Inc (NDRA) - SETE News
NDRA’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle
ENDRA Life Sciences (NASDAQ:NDRA) Shares Down 7.7% - Defense World
ENDRA Life Sciences Inc [NDRA] Investment Guide: What You Need to Know - Knox Daily
CEO Vacancy Triggers Management Shuffle At ENDRA Life Sciences - MPO-mag
ENDRA Life Sciences Inc (NDRA) deserves closer scrutiny - US Post News
Investor’s Toolkit: Key Ratios for Assessing ENDRA Life Sciences Inc (NDRA)’s Performance - The Dwinnex
CEO Vacancy Triggers Management Shuffle at ENDRA Life Sciences - MPO-mag
SEC Form PRE 14A filed by ENDRA Life Sciences Inc. - Quantisnow
Prepare Yourself for Liftoff: ENDRA Life Sciences Inc (NDRA) - SETE News
ENDRA Life Sciences stock hits 52-week low at $0.37 - Investing.com
Anchoring Your Portfolio: Is NDRA Stock a Safe Harbor? - The InvestChronicle
Endra Life Sciences Inc Stock (NDRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):